Literature DB >> 28791493

Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?

C Ekenberg1, I P Lodding2, N E Wareham2, S S Sørensen3, H Sengeløv4, F Gustafsson5, A Rasmussen6, M Perch5, J D Lundgren2, M Helleberg2.   

Abstract

Transplant recipients are at high risk of cytomegalovirus (CMV) infection. Mechanisms explaining the variation in risk of infections are far from fully elucidated. We hypothesised that host genetics explains part of the variation in risk of infection and examined if relatives of recipients with CMV infection have higher rates of severe infections compared to relatives of recipients without this infectious phenotype. In a register-based study, we included first-degree relatives of transplant recipients and examined the risk of hospitalisation due to overall infection or viral infection and risk of death among relatives of recipients who developed CMV infection within the first year of transplantation compared to relatives of recipients without CMV. Analyses were adjusted for sex, age and calendar year. We included 4470 relatives who were followed for 103,786 person-years, median follow-up 24 years [interquartile range (IQR) 12-36]. There were a total of 1360 infection-related hospitalisations in the follow-up period, incidence rate (IR) 13.1/1000 person-years [95% confidence interval (CI), 12.4; 13.8]. 206 relatives were hospitalised with viral infection, IR 1.8/1000 person-years (95% CI, 1.6; 2.0). There was no increased risk of hospitalisation due to infections, IR ratio (IRR) 0.99 (95% CI, 0.88; 1.12), nor specifically viral infections, IRR 0.87 (95% CI, 0.63; 1.19), in relatives of recipients with CMV compared to relatives of recipients without CMV. Also, no difference was seen in analyses stratified by transplant type, family relation and CMV serostatus. The risk of hospitalisation due to infection is not increased among first-degree relatives of transplant recipients with CMV infection compared to relatives of recipients without CMV.

Entities:  

Mesh:

Year:  2017        PMID: 28791493     DOI: 10.1007/s10096-017-3072-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.

Authors:  Thomas W Hoffmann; Jean-Michel Halimi; Mathias Büchler; Florence Velge-Roussel; Alain Goudeau; Azmi Al Najjar; Marie-Denise Boulanger; Tarik Sqalli Houssaini; Jean-Frédéric Marliere; Yvon Lebranchu; Christophe Baron
Journal:  Transplantation       Date:  2008-05-27       Impact factor: 4.939

2.  The Danish Civil Registration System.

Authors:  Carsten Bøcker Pedersen
Journal:  Scand J Public Health       Date:  2011-07       Impact factor: 3.021

3.  Factors associated with the development of cytomegalovirus infection following solid organ transplantation.

Authors:  Caspar da Cunha-Bang; Søren S Sørensen; Martin Iversen; Henrik Sengeløv; Jens G Hillingsø; Allan Rasmussen; Svend A Mortensen; Zoe V Fox; Nikolai S Kirkby; Claus B Christiansen; Jens D Lundgren
Journal:  Scand J Infect Dis       Date:  2011-02-09

4.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

5.  The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.

Authors:  C da Cunha-Bang; N Kirkby; M Sønderholm; S S Sørensen; H Sengeløv; M Iversen; A Rasmussen; F Gustafsson; C M Frederiksen; J Kjaer; A Cozzi Lepri; J D Lundgren
Journal:  Am J Transplant       Date:  2013-01-02       Impact factor: 8.086

6.  Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation.

Authors:  Oriol Manuel; Agnieszka Wójtowicz; Stéphanie Bibert; Nicolas J Mueller; Christian van Delden; Hans H Hirsch; Juerg Steiger; Martin Stern; Adrian Egli; Christian Garzoni; Isabelle Binet; Maja Weisser; Christoph Berger; Alexia Cusini; Pascal Meylan; Manuel Pascual; Pierre-Yves Bochud
Journal:  J Infect Dis       Date:  2014-10-09       Impact factor: 5.226

Review 7.  Human genetic susceptibility to infectious disease.

Authors:  Stephen J Chapman; Adrian V S Hill
Journal:  Nat Rev Genet       Date:  2012-02-07       Impact factor: 53.242

8.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

9.  Cancer risk in the relatives of patients with nasopharyngeal carcinoma—a register-based cohort study in Sweden.

Authors:  Z Liu; F Fang; E T Chang; W Ye
Journal:  Br J Cancer       Date:  2015-04-30       Impact factor: 7.640

10.  Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections.

Authors:  I P Lodding; H Sengeløv; C da Cunha-Bang; M Iversen; A Rasmussen; F Gustafsson; J G Downing; J Grarup; N Kirkby; C M Frederiksen; A Mocroft; S S Sørensen; J D Lundgren
Journal:  EBioMedicine       Date:  2015-05-08       Impact factor: 8.143

View more
  4 in total

1.  The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.

Authors:  Neval E Wareham; Amanda Mocroft; Henrik Sengeløv; Caspar Da Cunha-Bang; Finn Gustafsson; Carsten Heilmann; Martin Iversen; Nikolai S Kirkby; Allan Rasmussen; Søren Schwartz Sørensen; Jens D Lundgren
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-26       Impact factor: 4.553

2.  "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".

Authors:  Neval E Wareham; Qiuju Li; Henrik Sengeløv; Caspar Da Cunha-Bang; Finn Gustafsson; Carsten Heilmann; Michael Perch; Allan Rasmussen; Søren Schwartz Sørensen; Amanda Mocroft; Jens D Lundgren
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-05       Impact factor: 4.553

3.  Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients.

Authors:  Mark P Khurana; Isabelle P Lodding; Amanda Mocroft; Søren S Sørensen; Michael Perch; Allan Rasmussen; Finn Gustafsson; Jens D Lundgren
Journal:  Open Forum Infect Dis       Date:  2019-05-08       Impact factor: 3.835

4.  Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.

Authors:  I P Lodding; C da Cunha Bang; S S Sørensen; F Gustafsson; M Iversen; N Kirkby; M Perch; A Rasmussen; H Sengeløv; A Mocroft; J D Lundgren
Journal:  Open Forum Infect Dis       Date:  2018-04-17       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.